Cargando…
Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes – A multicenter retrospective study
PURPOSE: To report the initial experience of managing treatment-resistant and treatment-naïve eyes with polypoidal choroidal vasculopathy (PCV) by using brolucizumab 6 mg. METHODS: This was a retrospective multicentric series of all consecutive eyes with PCV treated with brolucizumab. Treatment resi...
Autores principales: | Chakraborty, Debdulal, Maiti, Aniruddha, Sengupta, Sabyasachi, Mondal, Soumen, Nandi, Krishnendu, Chakraborty, Somnath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240502/ https://www.ncbi.nlm.nih.gov/pubmed/35326038 http://dx.doi.org/10.4103/ijo.IJO_2513_21 |
Ejemplares similares
-
Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study
por: Chakraborty, Debdulal, et al.
Publicado: (2021) -
Incidence, clinical features, risk factors, and outcomes of Intraocular inflammation following Brolucizumab in Indian eyes – A multicentric study
por: Chakraborty, Debdulal, et al.
Publicado: (2023) -
Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study – Fifty-Two-Week Outcomes
por: Chakraborty, Debdulal, et al.
Publicado: (2022) -
Choroidal Vascular Abnormalities by Ultra-widefield Indocyanine Green Angiography in Polypoidal Choroidal Vasculopathy
por: Jeong, Areum, et al.
Publicado: (2021) -
Commentary: Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes - A multicenter retrospective study
por: Gopal, Lingam
Publicado: (2022)